Grocers take a hit from new weight-loss meds | Supermarket News
In recent times, a fascinating shift has occurred in consumer behavior, largely influenced by the rising use of GLP-1 weight-loss medications such as Ozempic. This change is highlighted in a comprehensive report by data analytics firm Numerator, which delves into the impact these drugs are having on grocery shopping trends. Initially developed for diabetes management, these medications are now increasingly used for weight loss, leading to notable declines in the purchase of various food items.
Dr. Leo Feler, Chief Economist at Numerator, points out that this trend is still in its early stages, yet its effects are already significant. A year ago, the primary use of GLP-1 medications was for diabetes, but now nearly half of the users are employing them for weight loss. The study, analyzing the habits of 100,000 GLP-1 drug users, indicates that there’s a growing interest among households to use these medications for weight loss, pending affordability and proven safety and effectiveness.
The most striking findings of the study relate to the changes in grocery spending habits. Those using GLP-1 drugs primarily for weight loss showed a 7.7% decrease in overall grocery spending, whereas those using them for diabetes management reduced spending by a lesser margin. Interestingly, the study reveals varying patterns in the purchase of specific items like ice cream, snacks, and frozen foods, depending on the weight loss goals of the users.
Moreover, the report underscores a broader impact across several grocery store departments. Users of GLP-1 medications for weight loss have curtailed their purchases in categories like bakery, snacks, breakfast items, and refrigerated foods by up to 20%. This trend is also evident in departments such as condiments, dairy, and produce, though to a lesser extent. These findings echo the observations made by Walmart CEO John Furner, who noted a discernible change in grocery shopping patterns among users of Ozempic, characterized by fewer units and calories………
[read more]
Rising Dough
In light of the emerging trends influenced by GLP-1 weight loss medications, consider the potential ripple effects on the economy and business sectors. How might this shift in consumer behavior impact industries beyond the grocery sector, such as health and wellness, food production, and marketing strategies?
*Click on the “Full Loaf” icon to read the full article! After you read the full article, let us know your thoughts.
Share this content:
The ripple effect of the weight-loss medications is that more and more people will probably buy it and use it but using these types of medication is dangerous because it can have many side effects and cause people to go to the hospital.
I think that this might ripple into a decrease in food production and food consumption. This might also cause a change in how companies market their medication to appeal to consumers on a weight loss journey.
The emergence of GLP-1 weight loss medications could definitely have ripple effects on various industries. In addition to the grocery sector, industries like health and wellness, food production, and marketing strategies might be impacted. For example, there could be an increased demand for healthier food options and products that align with weight loss goals. Companies in these industries might need to adjust their marketing strategies and product offerings to cater to this shift in consumer behavior.